Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Securities Class Action

Securities fraud litigation history and active cases

In Litigation

0

Settlement

0

Closed

2

Total Settlement

$0

INTERCEPT PHARMACEUTICALS, INC. (ICPT) Class Action Lawsuit (November 2020)

Closed

1:21cv36 • November 5, 2020

Class Period Start

September 27, 2019

Class Period End

October 8, 2020

PSLRA Deadline

January 4, 2021

Case Allegations

10b5

Statutes of Repose

Sep 27, 2022

Country

United States

Court

Federal Court

Docket History

Apr 20, 2022

No Appeal- Closed

Mar 21, 2022

Motion to Dismiss Granted

Apr 26, 2021

Motion to Dismiss

Mar 11, 2021

First Amended Complaint

Feb 8, 2021

Scheduling Order

Jan 25, 2021

Appointment of Lead Plaintiff

Jan 5, 2021

Scheduling Order

Nov 5, 2020

First Filed Complaint

INTERCEPT PHARMACEUTICALS, INC. (ICPT) Class Action Lawsuit (September 2017)

Closed

20-3488 • September 27, 2017

Class Period Start

June 9, 2016

Class Period End

September 20, 2017

PSLRA Deadline

November 27, 2017

Case Allegations

10b5

Statutes of Repose

Jun 9, 2019

Country

United States

Court

Federal Court

Docket History

Jul 20, 2022

Ruling on Appeal - Closed

Oct 9, 2020

On Appeal

Mar 27, 2020

Motion to Dismiss Granted

Oct 18, 2018

Scheduling Order

Sep 14, 2018

Motion to Dismiss

Jul 31, 2018

First Amended Complaint

Jun 1, 2018

Appointment of Lead Plaintiff

Jan 3, 2018

Scheduling Order

Sep 27, 2017

First Filed Complaint

TOP